在患有晚期慢性病与心力衰竭并存的患者中减少血栓塞
Carmine Zoccali1,2,3, Adeera Levin4, Francesca Mallamaci3
1Renal Research Institute, New York, NY, USA.
Clinical kidney journal
|July 4, 2025
概括
心力衰竭 (HF) 和慢性病 (CKD) 的管理包括解决液体拥堵问题. 策略包括利尿剂和较新的疗法,个性化护理对于更好的患者结果至关重要.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 心力衰竭 (HF) 和慢性病 (CKD) 分享相互关联的病理生理学,特别是液体拥堵.
- 在HF和CKD中的拥堵从血液动力学变化进展到肺,中间阶段如无症状的肺拥堵和脑中 natriuretic (BNP) 的升高.
研究的目的:
- 审查HF和CKD的相互联系,重点关注拥堵病理生理学.
- 讨论当前和新兴的流体过载管理策略在这些条件下.
主要方法:
- 对HF和CKD病理生理学和管理研究的文献综述.
- 对治疗方法的分析,包括限制,利尿剂,液体监测技术,SGLT-2抑制剂和超.
主要成果:
- 液体拥堵是HF和CKD的关键共享途径.
- 利尿剂是主要的治疗方法,但面临着诸如耐药性和副作用等挑战.
- 替代疗法和组合疗法,包括SGLT-2抑制剂和超过,是重要的考虑因素.
结论:
- 有效地管理高压和CKD需要解决流体拥堵的共同挑战.
- 个性化治疗策略对于优化同时存在HF和CKD的患者的临床结果至关重要.
相关概念视频
Heart Failure Drugs: Diuretics
500
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
500
Heart Failure VI: Adjunct Therapies
36
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
36
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
516
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
516
Heart Failure V: Medical Management
29
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
29
Chronic Kidney Disease IV: Nursing Management
60
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
60
Upper Respiratory Drugs: Decongestants
387
Decongestants are a class of medications used primarily to alleviate nasal congestion, a common symptom resulting from allergies, colds, sinusitis, and other upper respiratory tract infections. These drugs work by activating α-adrenergic receptors, constricting small blood vessels in the nasal membranes. This action results in the opening of clogged nasal passages, thereby facilitating sinus drainage and relieving congestion.
Most decongestants are readily available over-the-counter in...
Most decongestants are readily available over-the-counter in...
387


